Design, synthesis and biological evaluation of novel FGFR inhibitors bearing an indazole scaffold

2015 ◽  
Vol 13 (28) ◽  
pp. 7643-7654 ◽  
Author(s):  
Jian Liu ◽  
Xia Peng ◽  
Yang Dai ◽  
Wei Zhang ◽  
Sumei Ren ◽  
...  

Fibroblast growth factor receptor (FGFR) is a potential target for cancer therapy.


Author(s):  
Zhen Zhang ◽  
Dongmei Zhao ◽  
Yang Dai ◽  
Maosheng Cheng ◽  
Meiyu Geng ◽  
...  

Tyrosine kinase fibroblast growth factor receptor (FGFR), which is aberrant in various cancer types, is a promising target for cancer therapy. Here we reported the design, synthesis, and biological evaluation of a new series of 6-(2,6-dichloro-3,5-dimethoxyphenyl)-4-substituted-1H-indazoles derivatives as potent FGFR inhibitors. Compound 10a was first identified as a potent FGFR1 inhibitor, with good enzymatic inhibition. Further structure-based optimization revealed that compound 13a is the most potent FGFR1 inhibitor in this series with the enzyme inhibitory activity about 30.2 nM of IC50 value.



2011 ◽  
Vol 15 (7) ◽  
pp. 829-846 ◽  
Author(s):  
Christine Heinzle ◽  
Hedwig Sutterlüty ◽  
Michael Grusch ◽  
Bettina Grasl-Kraupp ◽  
Walter Berger ◽  
...  


2016 ◽  
Vol Volume 10 ◽  
pp. 2547-2560 ◽  
Author(s):  
Anna Szlachcic ◽  
Malgorzata Zakrzewska ◽  
Michal Lobocki ◽  
Piotr Jakimowicz ◽  
Jacek Otlewski


Sign in / Sign up

Export Citation Format

Share Document